Platelet Count-Agnostic Methods of Treating Myelofibrosis
Copyright © Targeted News Service 2024
2024-04-23
ALEXANDRIA, Virginia, April 24 -- GLAXOSMITHKLINE LLC, Wilmington, Delaware has been assigned a patent (No. US 11963962 B2, initially filed Aug. 21, 2019) developed by three inventors Barbara Jane Klencke, Plymouth, Michigan; Gregg David Smith, Plymouth, Michigan; and Rafe Michael Joseph Donahue, Plymouth, Michigan, for "Platelet count-agnostic methods of treating myelofibrosis." . . .